Reckitt Targets $500 Million of 2044 Notes in Debt Tidy-Up

Reckitt Benckiser Group PLC has launched a cash tender offer for all of the outstanding $500 million of 4.600% Mead Johnson Nutrition Company senior notes due in 2044.

The transaction is primarily relevant to bondholders, but shareholders should still pay attention. It could remove a chunk of long-dated gross debt from the group structure, although Reckitt has not disclosed how the purchase will be funded or what the final cash cost will be.

Alongside the tender, Mead Johnson is asking bondholders to approve changes that would remove substantially all restrictive covenants, eliminate certain events of default and release Reckitt's guarantee of the notes.

That consent request is the most important detail for any bondholder considering whether to remain invested.

Reckitt's tender offer at a glance

Detail	Announcement
Issuer	Mead Johnson Nutrition Company
Parent company	Reckitt Benckiser Group PLC
Notes outstanding	$500 million
Coupon	4.600%
Maturity	2044
Amount sought	Any and all outstanding notes
Pricing spread	30 basis points above the reference Treasury yield
Tender expiry	5pm New York time on 13 August 2026
Expected settlement	18 August 2026
Consent threshold	At least a majority of outstanding principal

The offer is described as an "any and all" tender, meaning Mead Johnson is willing to purchase every validly tendered note, subject to the offer's conditions.

There is no minimum amount that must be tendered. The offer is also not conditional upon Reckitt receiving the required level of bondholder consent, although the proposed changes to the bond terms cannot become operative unless at least a majority of the outstanding principal is accepted for purchase and paid for.

How will the purchase price be calculated?

The final consideration has not yet been disclosed.

Instead, the purchase price will be calculated using the yield on the 5.000% US Treasury bond due on 15 May 2046, plus a fixed spread of 30 basis points. One basis point is one-hundredth of a percentage point, so 30 basis points equals 0.30 percentage points.

The relevant Treasury yield is expected to be determined at 4pm New York time on 13 August 2026.

Bondholders whose notes are validly tendered and accepted will also receive accrued and unpaid interest from the previous interest payment date up to, but excluding, the settlement date.

The expected settlement date is 18 August 2026, although Mead Johnson can extend or terminate the process in accordance with the tender terms.

Full legal terms are available in the original company announcement.

Why is Reckitt seeking bondholder consent?

Mead Johnson is not simply offering to repurchase the bonds. It is also requiring participating holders to consent to substantial changes to the indenture, which is the legal agreement governing the notes.

The proposed amendments would:

• eliminate substantially all restrictive covenants
• remove certain events of default
• release Reckitt from its guarantee of Mead Johnson's payment obligations

Restrictive covenants are contractual protections that limit certain actions by a borrower. Events of default define circumstances that can give bondholders enforcement rights. Removing these terms would therefore weaken the protections attached to any notes left outstanding.

Bondholders cannot tender their notes without providing consent. Equally, they cannot provide consent without tendering. It is a combined decision rather than two separate votes.

The amendments require consent from holders representing at least a majority of the outstanding principal amount. They would only become operative once Mead Johnson has accepted and paid for at least that majority through the tender offer.

What happens to bonds that are not tendered?

Any notes that are not tendered and purchased will remain outstanding.

Mead Johnson would still be required to make scheduled principal and interest payments on those bonds. However, if the required majority approves the amendments and they become operative, the remaining bonds would lose substantially all restrictive covenants, certain default protections and Reckitt's guarantee.

That creates an important choice for holders. A bondholder choosing not to participate could be left owning a potentially smaller and less protected issue.

A smaller amount of bonds in circulation may also be less liquid, meaning it could become harder to buy or sell them efficiently. The announcement does not disclose how many holders intend to participate, so the eventual size of the remaining issue is not yet known.

What does the deal mean for Reckitt shareholders?

The direct effect is on bondholders rather than Reckitt's ordinary shareholders. This announcement contains no update on revenue, profit, cash generation, dividends or operating guidance.

The potential positive is that Reckitt could remove up to $500 million of gross debt due in 2044. Retiring debt can simplify a company's capital structure and remove future interest and repayment obligations associated with the purchased notes.

However, the tender will require cash. Reckitt has not disclosed the funding source, expected total consideration or any resulting effect on net debt. Without those details, it is not possible to determine the transaction's full impact on leverage or financial flexibility.

The 4.600% coupon gives investors a clear view of the annual contractual interest rate on the notes, but the announcement does not quantify any expected interest saving. The final amount saved will depend on how many bonds are accepted and whether replacement financing is involved.

Releasing Reckitt's guarantee may also reduce future obligations at the parent-company level for any notes left outstanding, although Mead Johnson would remain responsible for scheduled payments.

The key dates and conditions to watch

Bondholders can withdraw tendered notes and revoke related consents until 5pm New York time on 13 August 2026, unless the deadline is extended.

After that deadline, withdrawals will generally not be permitted except where required by law. Pricing is expected one hour before the offer expires, with settlement currently planned for 18 August.

For shareholders, the next useful information will be the amount of debt actually repurchased, the final cash consideration and whether the consent threshold is achieved.

Until those results arrive, this looks like a potentially meaningful liability-management exercise rather than a change to Reckitt's trading outlook. The main shareholder question is whether the simplification and reduction of gross debt justify the cash used to complete the transaction.